ArticleBMJ global health2019
Poor availability of essential medicines for women and children threatens progress towards Sustainable Development Goal 3 in Africa.
Article in BMJ global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The Effects of Maternal Iron and Folate Supplementation on Pregnancy and Infant Outcomes in Africa: A Systematic Review.International journal of environmental research and public health · 2024Pooled it
- Global, regional and national availability of essential medicines for children, 2009-2020: a systematic review and meta-analysis.BMC public health · 2023Pooled it
- Availability of essential medicines in conflict-affected african regions: a systematic review and meta-analysis.Conflict and health · 2026Review
- Article
- Inventory Management Performance for Lifesaving Maternal and Child Health Medicines in Amhara Regional State, Ethiopia: A Facility-Based Cross-Sectional Mixed Method Study.Health science reports · 2026Article
- Inequity in access to medications among communities in Eastern Ethiopia: a decomposition analysis.BMC health services research · 2025Article
- Breaking Barriers: Strengthening Health Equity in Sub-Saharan Africa Through Improved Local Pharmaceutical Production.Health and human rights · 2025Article
- Geographic equity in essential newborn care practices in Ethiopia: a cross-sectional study.BMC pediatrics · 2025Article
- National availability, prices and affordability of essential medicines: a comprehensive analysis using WHO/HAI methodology in Chad.The Pan African medical journal · 2025Article
- Availability, price and affordability of essential medicines for managing cardiovascular disease in Addis Ababa, Ethiopia.Scientific reports · 2024Article
- Effective Supply Chain Strategies in Addressing Demand and Supply Uncertainty: A Case Study of Ethiopian Pharmaceutical Supply Services.Pharmacy (Basel, Switzerland) · 2024Article
- Availability, pricing, and affordability of essential medicines for pediatric population in Malawi.Frontiers in pharmacology · 2024Article
- Assessment of prices, availability and affordability of essential medicines in Juba County, South Sudan.Journal of pharmaceutical policy and practice · 2023Article
- Assessment of availability and challenges of WHO recommended priority life-saving medicines for under five-year children in primary public health facilities of Amhara region.BMC pediatrics · 2023Article
- Assessment of hypertension service availability in some primary health centres in Nigeria: a mixed-methods study.BMJ open · 2023Article
- Article
- Knowledge, attitudes and practices of healthcare professionals on the use of an electronic stock visibility and management tool in a middle-income country: Implications for access to medicines.Exploratory research in clinical and social pharmacy · 2023Article
- Spatiotemporal distributions of under-five mortality in Ethiopia between 2000 and 2019.PLOS global public health · 2023Article
- Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review.ClinicoEconomics and outcomes research : CEOR · 2023Article
- Availability and affordability of priority lifesaving maternal health medicines in Addis Ababa, Ethiopia.BMC health services research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMost maternal and child deaths are preventable or treatable with proven, cost-effective interventions for infectious diseases and maternal and neonatal complications. In 2015 sub-Saharan Africa accounted for up to 66% of global maternal deaths and half of the under-five deaths. Access to essential medicines and commodities and trained healthcare workers to provide life-saving maternal, newborn and post-natal care are central to further reductions in maternal and child mortality.
methodsAvailable data for 24 priority medicines for women and children were extracted from WHO service availability and readiness assessments conducted between 2012 and 2015 for eight countries in sub-Saharan Africa. The mean availability of medicines in facilities stating they provide services for women or children and differences by facility type, ownership and location are reported.
resultsThe mean availability of 12 priority essential medicines for women ranged from 22% to 40% (median 33%; IQR 12%) and 12 priority medicines for children ranged from 28% to 57% (median 50%; IQR 14%). Few facilities (<1%) had all nominated medicines available. There was higher availability of priority medicines for women in hospitals than in primary care facilities: range 32%-80% (median 61%) versus 20%-39% (median 23%) and for children's medicines 31%-71% (median 58%) versus 27%-57% (median 48%). Availability was higher in public than private facilities: for women's medicines, range 21%-41% (median 34%) versus 4%-36% (median 27%) and for children's medicines 28%-58% (median 51%) versus 5%-58% (median 46%). Patterns were mixed for rural and urban location for the priority medicines for women, but similar for children's medicines.
conclusionsThe survey results show unacceptably low availability of priority medicines for women and children in the eight countries. Governments should ensure the availability of medicines for mothers and children if they are to achieve the health sustainable development goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.